Oligomerix, Inc.
- Biotech or pharma, therapeutic R&D
Oligomerix, Inc., is a clinical stage biotechnology company pioneering the development of disease-modifying, oral small molecule therapeutics targeting protein aggregation in Alzheimer’s disease and rare neurodegenerative diseases such as PSP.
No vendors please.
Address
White Plains, NYNew York
United States
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}